US Patent 9549903 Transdermal delivery system comprising buprenorphine
Patent 9549903 was granted and assigned to Purdue Pharma on January, 2017 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9549903 Transdermal delivery system comprising buprenorphine
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.